Paxlovid speeds up recovery but doesn’t cut hospitalizations for the vaccinated, NEJM study finds
TL;DR
A New England Journal of Medicine analysis of Canadian and UK trials (about 4,200 participants) found Paxlovid does not reduce hospitalizations or death in a largely vaccinated population, though users recovered about three days faster; the results could influence how public funding and prescriptions are targeted for antivirals.
- A new study looked into the effectiveness of the COVID-19 drug Paxlovid. Here’s what the results showed. CTV News
- If It's COVID, Paxlovid? Studies Suggest a Rethink These Days MedPage Today
- Paxlovid doesn’t reduce hospitalization, death rates in vaccinated high-risk COVID outpatients, trial shows CIDRAP
- Paxlovid looked like a COVID game-changer, but in vaccinated adults the real story is far more complicated Medical Xpress
- COVID antiviral speeds recovery, but doesn’t reduce hospitalization in vaccinated patients UBC Faculty of Medicine
Want the full story? Read the original reporting
Read on CTV News